Literature DB >> 20579726

Degradable, pH-sensitive, membrane-destabilizing, comb-like polymers for intracellular delivery of nucleic acids.

Yen-Ling Lin1, Guohua Jiang, Lisa K Birrell, Mohamed E H El-Sayed.   

Abstract

This report describes the design and synthesis of a new series of degradable, pH-sensitive, membrane-destabilizing, comb-like polymers that can enhance the intracellular delivery of therapeutic nucleic acids. These comb-like polymers are based on a diblock polymer backbone where the first block is a copolymer of pH-sensitive ethyl acrylic acid (EAA) monomers and hydrophobic butyl methacrylate (BMA) or hexyl methacrylate monomers. The second block is a homopolymer of N-acryloxy succinimide (NASI) or ss-benzyl l-aspartate N-carboxy-anhydride (BLA-NCA) monomers, which are functionalized to allow controlled grafting of hydrophobic HMA and cationic trimethyl aminoethyl methacrylate (TMAEMA) copolymers via acid-labile hydrazone linkages. These comb-like polymers displayed high hemolytic activity in acidic solutions, which increased with the increase in polymer concentration. All comb-like polymers degraded into small fragments upon incubation in an acidic solution (pH 5.8) due to hydrolysis of the hydrazone linkages connecting the hydrophobic/cationic grafts to the polymer backbone. Comb-like polymers successfully complexed anti-GAPDH siRNA molecules into serum- and nuclease-stable particles, which successfully silenced GAPDH expression at both the mRNA and protein levels. These results collectively indicate the potential of these new comb-like polymers to serve as vehicles for effective intracellular delivery of therapeutic nucleic acids. Copyright (c) 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20579726     DOI: 10.1016/j.biomaterials.2010.05.048

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  14 in total

1.  Toward Personalized Peptide-Based Cancer Nanovaccines: A Facile and Versatile Synthetic Approach.

Authors:  Hamilton Kakwere; Elizabeth S Ingham; Riley Allen; Lisa M Mahakian; Sarah M Tam; Hua Zhang; Matthew T Silvestrini; Jamal S Lewis; Katherine W Ferrara
Journal:  Bioconjug Chem       Date:  2017-10-13       Impact factor: 4.774

Review 2.  Non-condensing polymeric nanoparticles for targeted gene and siRNA delivery.

Authors:  Jing Xu; Shanthi Ganesh; Mansoor Amiji
Journal:  Int J Pharm       Date:  2011-05-19       Impact factor: 5.875

3.  Design and evaluation of new pH-sensitive amphiphilic cationic lipids for siRNA delivery.

Authors:  Anthony S Malamas; Maneesh Gujrati; China M Kummitha; Rongzuo Xu; Zheng-Rong Lu
Journal:  J Control Release       Date:  2013-06-21       Impact factor: 9.776

4.  Light-mediated activation of siRNA Release in diblock copolymer assemblies for controlled gene silencing.

Authors:  Abbygail A Foster; Chad T Greco; Matthew D Green; Thomas H Epps; Millicent O Sullivan
Journal:  Adv Healthc Mater       Date:  2014-12-22       Impact factor: 9.933

5.  Controlled Endolysosomal Release of Agents by pH-responsive Polymer Blend Particles.

Authors:  Xi Zhan; Kenny K Tran; Liguo Wang; Hong Shen
Journal:  Pharm Res       Date:  2015-01-16       Impact factor: 4.200

6.  A bioreducible polymer for efficient delivery of Fas-silencing siRNA into stem cell spheroids and enhanced therapeutic angiogenesis.

Authors:  Min Suk Shim; Suk Ho Bhang; Kyunghwan Yoon; Kyunghee Choi; Younan Xia
Journal:  Angew Chem Int Ed Engl       Date:  2012-10-16       Impact factor: 15.336

7.  Synthesis of water-soluble poly(α-hydroxy acids) from living ring-opening polymerization of O-benzyl-L-serine carboxyanhydrides.

Authors:  Yanbing Lu; Lichen Yin; Yanfeng Zhang; Zhang Zhonghai; Yunxiang Xu; Rong Tong; Jianjun Cheng
Journal:  ACS Macro Lett       Date:  2012-04-17       Impact factor: 6.903

8.  Synergistic combination of small molecule inhibitor and RNA interference against antiapoptotic Bcl-2 protein in head and neck cancer cells.

Authors:  Yen-Ling Lin; Yasemin Yuksel Durmaz; Jacques E Nör; Mohamed E H ElSayed
Journal:  Mol Pharm       Date:  2013-06-18       Impact factor: 4.939

Review 9.  Journey to the Center of the Cell: Current Nanocarrier Design Strategies Targeting Biopharmaceuticals to the Cytoplasm and Nucleus.

Authors:  Erik V Munsell; Nikki L Ross; Millicent O Sullivan
Journal:  Curr Pharm Des       Date:  2016       Impact factor: 3.116

10.  Silencing bcl-2 expression in epithelial cancer cells using "smart" particles.

Authors:  Yen-Ling Lin; Guohua Jiang; Zhaocheng Zhang; Jacques E Nör; Mohamed E H ElSayed
Journal:  J Funct Biomater       Date:  2014-09-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.